STOCKSCOUTER

StockScouter Premium

StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance

INCY INCYTE CORPORATION StockScouter® Report

7

StockScouter® Score

INCYTE CORPORATION, a mid cap growth company in the healthcare sector, is expected to outperform the market over the next six months with slightly less than average risk

10 is the best possible rating. Learn more.

Summary

Positives

  • The most recent quarterly earnings report was significantly higher than analysts’ consensus forecast. Positive
  • Moving average analysis for INCY suggests strong price movement over the medium term. Positive

 

Concerns

  • The ratio of INCY’s forward price-to-earnings multiple to its estimated growth rate is well above the average of comparably-sized companies in the StockScouter universe. Negative
  • One or more analysts has modestly decreased quarterly earnings estimates for INCY. Negative

 

Short-term Outlook

Over the next 1-2 months, StockScouter forecasts that mid cap stocks will be out of favor, growth stocks will be out of favor, and healthcare stocks will be out of favor.

Expected Risk/Return

Progress: 40% done.
Progress: 100% done.
Low
High

Core Model Grades

A
D
C
B

Previous Ratings

7
7
7